Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen abruptly puts 70 employees on paid leave
InsuranceNewsNet.com
Friday, June 6, 2014 - 10:50am
tags:
Amgen, layoffs
Glaxosmithkline Plc Completes Acquisition Of Human Genome Sciences
Reuters
Friday, June 6, 2014 - 10:09am
tags:
GSK, M&A, Human Genome Sciences
FDA Approves Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for Metastatic Colorectal Cancer
Reuters
Friday, June 6, 2014 - 10:08am
tags:
FDA, Sanofi, Regneron, Zaltrap, colorectal cancer
GW Pharma receives FDA fast-track designation for Dravet syndrome treatment
Reuters
Friday, June 6, 2014 - 10:07am
tags:
FDA, GW Pharma, fast track, Dravet syndrome, Epidiolex
Should Medtronic Buy Smith & Nephew?
Motley Fool
Friday, June 6, 2014 - 10:06am
tags:
Medtronic, Smith & Nephew, devices, M&A
How Gilead Sciences Can Deliver A Double
Forbes
Friday, June 6, 2014 - 10:05am
tags:
Gilead Sciences, Sovaldi
Bluebird, Agios: Preview of Next Week's Important Pipeline Updates
TheStreet.com
Friday, June 6, 2014 - 9:34am
tags:
Bluebird Bio, Agios, AG-221, Celgene, LentiGlobin
5 Reasons Why We Believe Novogen Is Poised For Success
Seeking Alpha
Thursday, June 5, 2014 - 10:57pm
tags:
Novogen, cancer, stem cells
Positive Data on Vertex Pharma's Kalydeco
Yahoo/Zacks.com
Thursday, June 5, 2014 - 10:56pm
tags:
Kalydeco, Vertex Pharmaceuticals, cystic fibrosis
2 Reasons to Watch Amgen
Motley Fool
Thursday, June 5, 2014 - 10:55pm
tags:
Amgen
Bristol Shares Sag On Cancer Drug Worries
Forbes
Thursday, June 5, 2014 - 10:53pm
tags:
Bristol-Myers Squibb, Yervoy, nivolumab, cancer
Sanofi Chief Sees No Reason to Join Pharma M&A Frenzy
Bloomberg
Thursday, June 5, 2014 - 10:52pm
tags:
Sanofi, M&A, Chris Viehbacher, Pharma CEOs
Is Valeant’s Big Offer for Allergan Big Enough?
Motley Fool
Thursday, June 5, 2014 - 12:22pm
tags:
Valeant Pharmaceuticals, M&A, Allergan
Syndax sets terms for a $69M IPO to support its 'breakthrough' drug
Fierce Biotech
Thursday, June 5, 2014 - 12:17pm
tags:
Syndax Pharma, IPOs, breast cancer, breakthrough therapies, entinostat
GSK starts phase III of coronary drug test
Reuters
Thursday, June 5, 2014 - 12:10pm
tags:
GSK, losmapimod, acute coronary syndrome
Bayer says Dieter Weinand to head pharmaceuticals business
Reuters
Thursday, June 5, 2014 - 12:08pm
tags:
Bayer, Dieter Weinand
As FDA Takes Notice of Patients, Groups Trying to Influence Regulatory Policy do as Well
Regulatory Focus
Thursday, June 5, 2014 - 12:06pm
tags:
FDA, patients, PhRMA
Did Retrophin's CEO Share More Than Good Cheer in Twitter Posts?
Bloomberg/Businessweek
Thursday, June 5, 2014 - 12:05pm
tags:
Retrophin, twitter, social media
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Yahoo/Benzinga
Thursday, June 5, 2014 - 12:04pm
tags:
ASCO, cancer immunotherapy, Bristol-Myers Squibb, Yervoy, Merck, MK-3475
Shire’s Best Takeover Defense Is Deal Offense: Real M&A
Bloomberg
Thursday, June 5, 2014 - 12:02pm
tags:
M&A, Shire, NPS Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.